| Dec, 19 | Avastin approved in Europe for first-line treatment of patients with advanced kidney cancer more.. |
| Dec, 13 | Roche launches Employee Secondment Policy more.. |
| Dec, 11 | Changes to the Corporate Executive Committee more.. |
| Dec, 6 | Roche to nominate independent directors for election at Ventana`s 2008 annual stockholders meeting more.. |
| Nov, 30 | More than 12000 Roche employees take to the streets to help AIDS orphans - 1400 walkers throughout Switzerland, 1000 of them in Basel more.. |
| Nov, 21 | Roche Submits Application for FDA Approval of Actemra for the Treatment of Rheumatoid Arthritis more.. |
| Nov, 16 | Avastin receives positive opinion in Europe for first-line treatment of patients with advanced kidney cancer more.. |
| Nov, 15 | FDA approves Mircera: first renal anemia treatment in the US with monthly maintenance dosing more.. |
| Nov, 14 | Roche Confirms Commencement of Due Diligence with Ventana more.. |
| Nov, 13 | Roche signs licensing and settlement agreements for Hepatitis C immunodiagnostics more.. |
| Nov, 2 | Treatment with Pegasys provides hepatitis C patients a second chance to achieve a cure after not responding to Peg-Intron more.. |
| Oct, 23 | Roche Considering Legal Options In Patent Litigation Case more.. |
| Oct, 22 | Tarceva approved for lung cancer in Japan more.. |
| Oct, 19 | European licence for Roche HIV drug Viracept re-established by European Commission more.. |
| Oct, 19 | Pivotal Mircera study first to convert dialysis patients from frequent dosing directly to once every four weeks more.. |
| Oct, 16 | Japanese Red Cross selects Roche as partner for nucleic acid screening of entire Japanese blood supply more.. |
| Oct, 16 | Strong sales growth in the first nine months of 2007 - full-year outlook and Core Earnings per Share target reaffirmed more.. |
| Oct, 2 | Jürgen Schwiezer named new CEO Division Roche Diagnostics - Succession to take effect as of January 1, 2008 more.. |
| Sep, 28 | Roche confirms site development plans: go-ahead for office high-rise more.. |
| Sep, 26 | Herceptin eradicates tumours and may reduce the need for mastectomies in women with inflammatory HER2-positive breast cancer - one of the most aggressive and fastest growing forms of the disease more.. |
| Sep, 20 | European licence for Roche HIV drug Viracept recommended for re-instatement more.. |
| Sep, 20 | Roche wins first Financial Times / Citi Private Bank Environmental Award and was reselected for inclusion in the Dow Jones Sustainability Indexes more.. |
| Sep, 20 | New child sized Tamiflu capsules receive European approval more.. |
| Aug, 24 | Avastin approved in Europe for first-line treatment of patients with advanced lung cancer more.. |
| Aug, 21 | Roche extends tender offer for Ventana more.. |
| Aug, 13 | Roche and Actavis agree on product transactions more.. |
| Jul, 26 | Roche extends tender offer for Ventana more.. |
| Jul, 25 | Roche Announces Expiration of HSR Waiting Period for Ventana Offer more.. |
| Jul, 25 | Actemra monotherapy demonstrates significant clinical benefit in patients with rheumatoid arthritis more.. |
| Jul, 23 | Smaller size capsules of flu drug Tamiflu receive positive opinion in Europe more.. |
| Jul, 20 | Avastin receives positive opinion in Europe for first-line treatment of patients with advanced lung cancer more.. |
| Jul, 19 | Severin Schwan to succeed Franz B. Humer as Chief Executive of the Roche Group at the March 2008 shareholders meeting more.. |
| Jul, 19 | Roche in the first half of 2007: Strong performance continues more.. |
| Jul, 11 | Roche says offer for Ventana Medical Systems, Inc. is full and fair more.. |
| Jul, 9 | Roche and Alnylam form major alliance on RNAi therapeutics more.. |
| Jun, 27 | Preliminary results for phase III study evaluating CellCept in lupus nephritis more.. |
| Jun, 25 | Roche makes offer to acquire Ventana for 75 US dollars per share in cash more.. |
| Jun, 25 | Roche and Toyama Chemical enter licensing agreement to develop potential breakthrough drug to treat rheumatoid arthritis more.. |
| Jun, 25 | Once monthly Mircera could save about 50% of the time health professionals spend on anaemia management in dialysis centres each year more.. |
| Jun, 21 | Roche establishes Viracept Patient Registries in the interest of patient care more.. |
| Jun, 19 | Roche acquires NimbleGen to gain entry into high-growth research microarrray market more.. |
| Jun, 15 | Actemra: Roche´s novel rheumatoid arthritis drug shows substantial benefits for patients in OPTION study more.. |
| Jun, 6 | Roche recalls Viracept due to chemical impurity more.. |
| Jun, 6 | Actemra: New data confirms significant improvement of disease signs and symptoms in patients with rheumatoid arthritis more.. |
| Jun, 4 | Investigational cancer drug Pertuzumab shows promising results in advanced breast cancer when combined with Herceptin more.. |
| Jun, 4 | Avastin significantly prolongs progression free survival in advanced kidney cancer more.. |
| Jun, 4 | MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma than chemotherapy alone more.. |
| May, 29 | New AIDS Technology Transfers free of charge reinforce Roche´s commitment to strengthen local manufacturing in Africa more.. |
| May, 25 | Mircera receives positive opinion in Europe for the treatment of anaemia due to chronic kidney disease more.. |
| May, 21 | Roche receives approvable letter for Mircera in the United States more.. |
| May, 14 | Highly sensitive and accurate Roche HIV-1 Test approved by FDA more.. |
| May, 11 | Roche opens ultra-modern biotechnology production centre in Basel; construction completed in just two years more.. |
| May, 3 | Herceptin approved in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2 and hormone receptor-co-positive metastatic breast cancer more.. |
| Apr, 26 | Roche update on Tamiflu for pandemic influenza preparedness more.. |
| Apr, 18 | Breakthrough cancer drug Avastin approved in Japan for use in advanced or recurrent colorectal cancer more.. |
| Apr, 18 | Roche posts strong first quarter sales - upgrade of Core Earnings per Share outlook for 2007 more.. |
| Apr, 11 | Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases more.. |
| Apr, 4 | Roche to acquire BioVeris to expand its leading ECL immunochemistry business into new market segments more.. |
| Apr, 2 | Roche acquires THP to expand its therapeutic antibody research more.. |
| Mar, 30 | Xeloda approved in Europe for the treatment of advanced stomach cancer more.. |
| Mar, 29 | Avastin approved in Europe for first line treatment of women with metastatic breast cancer more.. |
| Mar, 29 | Roche acquires 454 Life Sciences to strengthen presence in ultra-fast gene sequencing more.. |
| Mar, 27 | Roche submits application to the FDA for use of XELOX (Xeloda plus oxaliplatin) with or without Avastin for the treatment of advanced colorectal cancer more.. |
| Mar, 26 | Herceptin receives positive opinion in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2- and hormone receptor-positive metastatic breast cancer more.. |
| Mar, 5 | Roche raises dividend by 36 percent more.. |
| Feb, 26 | Positive recommendation for Avastin use in advanced or recurrent colorectal cancer in Japan more.. |
| Feb, 23 | Recruitment temporarily suspended into C.E.R.A. Phase II oncology trial more.. |
| Feb, 23 | Oral cancer drug Xeloda receives positive opinion from the European Authorities for the treatment of advanced gastric cancer more.. |
| Feb, 23 | Avastin receives positive opinion in Europe for first-line treatment of women with metastatic breast cancer more.. |
| Feb, 22 | New phase III study confirms positive outcome of Avastin in patients with advanced lung cancer more.. |
| Feb, 20 | Roche and GSK agree on two transactions more.. |
| Feb, 16 | Roche files application in Europe for Tamiflu 30 and 45 mg capsules more.. |
| Feb, 7 | Annual Media Conference more.. |
| Feb, 7 | Roche posts outstanding results for 2006 more.. |
| Feb, 5 | Roche continues to strengthen Research and Development more.. |
| Jan, 29 | Tarceva : European approval for pancreatic cancer treatment more.. |
| Jan, 26 | Copegus approved in Japan as combination therapy with Pegasys for patients with chronic hepatitis C more.. |
| Jan, 24 | First Actemra multinational phase III trial demonstrates significant improvement in signs and symptoms of rheumatoid arthritis more.. |
| Jan, 10 | NeoRecormon gains European approval for convenient once weekly treatment of anaemia in patients with solid cancers more.. |
print this page